Subscribe

Serologic Staging System for Diffuse Large Cell Non-Hodgkin's Lymphoma Using Initial Serum Lactate Dehydrogenase and beta-2-Microglobulin Levels

Specialty:

Hematology Oncology

Objective:

ICD-10:

Description:

Pretreatment serum levels of lactate dehydrogenase (LD) and beta-2-microglobulin correlate with both the time to treatment failure and the survival seen in patients with diffuse large cell non-Hodgkin's malignant lymphoma. Three prognostic groups (low risk, intermediate risk, high risk) could be identified based upon the serum levels of these 2 analytes.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone